- ￥850 - 6200
- MedChemExpress(MCE)
- 美国
- HY-19636
- 2025年07月12日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- 规格：
10 mM * 1 mL/5 mg/10 mg/25 mg/50 mg/100 mg
| 规格： | 10 mM * 1 mL | 产品价格： | ￥1320.0 |
|---|---|---|---|
| 规格： | 5 mg | 产品价格： | ￥850.0 |
| 规格： | 10 mg | 产品价格： | ￥1360.0 |
| 规格： | 25 mg | 产品价格： | ￥2750.0 |
| 规格： | 50 mg | 产品价格： | ￥4200.0 |
| 规格： | 100 mg | 产品价格： | ￥6200.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
JNJ-42165279
CAS No. : 1346528-50-4
MCE 国际站：JNJ-42165279
产品活性：JNJ-42165279是FAAH抑制剂, 抑制 hFAAH和 rFAAH, IC50分别为70±8 nM 和 313 ± 28 nM。
研究领域：Metabolic Enzyme/Protease | Neuronal Signaling | Autophagy
相关产品：Covalent Screening Library Plus | Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Metabolism/Protease Compound Library | Neuronal Signaling Compound Library | Clinical Compound Library | Autophagy Compound Library | Drug Repurposing Compound Library | Covalent Screening Library | Anti-COVID-19 Compound Library | Lipid Metabolism Compound Library | Pain-Related Compound Library | Cysteine Targeted Covalent Library | Cell Death Library | Carprofen | Biochanin A | JZL195 | MAGL-IN-5 | Redafamdastat | URB-597 | PF-3845 | BIA 10-2474 | JNJ-1661010 | FAAH-IN-2 | LY2183240 | AA38-3 | URB937 | 1-Monomyristin | AM 374 | FP-Biotin | N-Arachidonoylserotonin | N-Benzylpalmitamide | N-Benzyllinolenamide | SA 47 | SSR411298 | TC-F2 | VU534 | AM1172 | Carpro-AM1 | CB2R/FAAH modulator-1 | CB2R/FAAH modulator-2 | CB2R/FAAH modulator-3
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Treatment of Infections Due to Resistant Staphylococcus aureus
, delafloxacin, and JNJ-Q2. Thus, there are currently many effective drugs to treat resistant S. aureus infections and many promising agents in the pipeline. Nevertheless, S. aureus remains a formidable adversary, and despite our deep bullpen of potential
Characterization of Histaminergic Receptors
H 4 Antagonists Thioperamide >100,000 >100,000 72.6 27 d Tocris Cookson JNJ7777140 c >10,000
技术资料暂无技术资料 索取技术资料
